KNCV Knowledge Institute

The KNCV Knowledge Institute brings together the research and innovation expertise within our network. The Knowledge Institute aims to showcase our track record in research and innovation related to TB-associated health issues, and health systems.

KNCV Knowledge Institute objectives

The KNCV Knowledge Institute objectives are:

  1. To ensure that KNCV-supported innovations are at the forefront of research and development in the field, with a focus on quality assurance. Any innovations that prove to be effective will be effectively communicated and widely applied across KNCV-supported countries and beyond. This will facilitate national, regional, or global scale, as appropriate.
  2. To formalize relationships with universities and training institutes, to ensure that they are mutually beneficial and promote clear knowledge transfer. This involves consolidating and structuring the KNCV internship and exchange program. This will enhance KNCV’s expertise in TB and related health issues and support the development of future leaders in the field.

To establish KNCV as a reference centre for TB research, innovation, and project implementation, we are undertaking a systematic effort to raise awareness of our existing resources.


KNCV Knowledge Institute expected outcomes by 2025:

  • KNCV-supported research and innovations are easily accessible and visible on the KNCV websites worldwide and in KNCV communications
  • KNCV research network mapped, clearly displayed on KNCV websites worldwide and up to date
  • KNCV alumni network formed and engaged for dissemination and feedback
  • KNCV Knowledge Institute newsletter published at least twice a year and disseminated across KNCV worldwide, the KNCV research network and partners
  • All study protocols are reviewed by the KNCV ERB
  • The proceedings of KNCV ERB meetings are systematically documented
  • A social scientist involved in all qualitative research at KNCV 


More information

Read more about our Ethical Review Board (ERB), our Experts and our Publications.

Read more

  • Breath by breath, Lucas’ journey towards the IRONMAN 2024

    Lucas is a 24 years-old, sports enthusiast and…

    Lees meer
  • 11/06/2024

    Thank you Wieneke!

    Upon completing her two terms, Wieneke Meijer has stepped down as a Member BoT during the General Assembly of KNCV…

    Lees meer
  • 10/06/2024

    Highlights from our Mini Symposium on Next Generation Sequencing for the diagnosis and surveillance of infectious diseases and antimicrobial drug resistance!

    Genome sequencing is one of the many novel tools that support our fight against AMR, TB and other infectious diseases.

    Lees meer
  • 06/06/2024

    Join us at the European Advanced Course on Clinical Tuberculosis (EACCTB)

      Here you can find the Progam EACCTB 2024. And to register and find further…

    Lees meer
  • 06/06/2024

    Launch of KNCV’s self-assessment checklist and planning tool

    KNCV launches a Self-assessment checklist and planning tool to assess the opportunities and barriers for programmatic introduction of the shorter…

    Lees meer
  • KNCV’s Self-assessment checklist and planning tool

    Assessing the opportunities and barriers for programmatic introduction of the shorter regimens with KNCV Self-assessment checklist and planning tool The…

    Lees meer
  • 05/06/2024

    New study highlights the impact of Stool-Based Xpert test on childhood TB diagnosis in Nigeria

    A recent study conducted in Nigeria revealed the significant impact of stool-based Xpert testing on childhood tuberculosis…

    Lees meer
  • Join us at the European Advanced Course on Clinical Tuberculosis (EACCTB)

    Thank you for your interest in this course! Here you can find the Progam EACCTB…

    Lees meer
  • 29/05/2024

    European Initiative to Accelerate TB Prevention and Screening: A Collaborative Effort

    The European Prevention and Systematic Screening Initiative to End TB (PASS to End TB) is a critical response to the…

    Lees meer
  • Ethical review board (ERB)

    Strengthening global research and innovation capacity is essential in the fight against TB, and KNCV recognizes the importance of this…

    Lees meer
  • KNCV Partners

    KNCV thanks all partners for their collaboration and support!   In the Netherlands: – ABN AMRO Group – Academic Medical…

    Lees meer
  • 21/05/2024

    Exploring the future of health prioritization: The People-Centred Framework at the Priorities Conference 2024

    The 14th Conference of the International Society for Priorities in Health (ISPH) – Priorities Conference 2024 –,…

    Lees meer
  • 03/05/2024

    Stool-based testing method: A revolutionary, convenient, accurate and pain-free approach to diagnose childhood tuberculosis

    In a recent study, conducted by the Ethiopian Public Health Institute (EPHI), KNCV…

    Lees meer
  • 22/04/2024

    Shorter DR-TB treatment regimens and cardiac monitoring

    Cardiac monitoring for people on novel short DR-TB treatment regimens can be decentralized and accessible. Dealing…

    Lees meer
  • 15/04/2024

    Private sector TB care can better capacity for primary treatment

    With the right incentives and administrative backing, informal healthcare providers and pharmacists can become partners in the country’s public health…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.